On Monday, Fulcrum Therapeutics Inc (NASDAQ: FULC) was 11.56% up from the session before settling in for the closing price of $8.65. A 52-week range for FULC has been $2.32 – $10.11.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 54.59%. When this article was written, the company’s average yearly earnings per share was at -637.50%. With a float of $47.99 million, this company’s outstanding shares have now reached $54.11 million.
Fulcrum Therapeutics Inc (FULC) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Fulcrum Therapeutics Inc stocks. The insider ownership of Fulcrum Therapeutics Inc is 11.33%, while institutional ownership is 89.98%. The most recent insider transaction that took place on May 08 ’25, was worth 2,520. In this transaction Principal Accounting Officer of this company sold 498 shares at a rate of $5.06, taking the stock ownership to the 14,062 shares.
Fulcrum Therapeutics Inc (FULC) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.31 earnings per share (EPS) during the time that was less than consensus figure (set at -0.29) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
Fulcrum Therapeutics Inc (NASDAQ: FULC) Trading Performance Indicators
You can see what Fulcrum Therapeutics Inc (FULC) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 17.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.18, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -1.22 in one year’s time.
Technical Analysis of Fulcrum Therapeutics Inc (FULC)
The latest stats from [Fulcrum Therapeutics Inc, FULC] show that its last 5-days average volume of 0.7 million was superior to 0.58 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 80.86%.
During the past 100 days, Fulcrum Therapeutics Inc’s (FULC) raw stochastic average was set at 88.37%, which indicates a significant increase from 85.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.84 in the past 14 days, which was higher than the 0.55 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.56, while its 200-day Moving Average is $6.17. Now, the first resistance to watch is $10.11. This is followed by the second major resistance level at $10.58. The third major resistance level sits at $11.40. If the price goes on to break the first support level at $8.82, it is likely to go to the next support level at $8.00. The third support level lies at $7.53 if the price breaches the second support level.
Fulcrum Therapeutics Inc (NASDAQ: FULC) Key Stats
There are 54,118K outstanding shares of the company, which has a market capitalization of 522.24 million. As of now, sales total 80,000 K while income totals -9,730 K. Its latest quarter income was 0 K while its last quarter net income were -19,600 K.
